...Sylvant siltuximab, a chimeric mAb against IL-6, to treat multicentric Castleman’s disease. XBiotech Inc. and MegaPharm Ltd....

...XBiotech granted MegaPharm rights to commercialize Xilonix in Israel to treat advanced colorectal cancer. XBiotech will...
...payment and is eligible for commercial and regulatory milestones, and XBiotech will provide Xilonix to MegaPharm...
...early as 4Q16. The companies declined to disclose financial terms. XBiotech Inc. (NASDAQ:XBIT), Austin, Texas MegaPharm Ltd....

...Pharming said partner MegaPharm Ltd. (Raanana, Israel) received marketing approval and full reimbursement in Israel for Ruconest...
...for Ruconest conestat alfa to treat acute angioedema attacks in adults with hereditary angioedema (HAE). MegaPharm...
...to launch the recombinant human complement 1 (C1) esterase inhibitor in the country this quarter. MegaPharm...

...in patients with epilepsy ages >=12 years. Eisai said the drug will be commercialized by MegaPharm Ltd....

...Israel approved the product as Fanapt to treat schizophrenia. Vanda will supply the product to MegaPharm Ltd....

...BLA YE12 Pfizer Inc. (NYSE:PFE) Tofacitinib RA PDUFA date August Pharming Group N.V. (Euronext:PHARM)/Hyupjin Corp. /MegaPharm Ltd./Santarus...

...retains rights to the histamine receptor agonist in all territories not licensed to Meda or MegaPharm Ltd....

...Vanda granted Megapharm exclusive commercialization rights to schizophrenia drug Fanapt iloperidone in Israel. Vanda said a...
...Israel in May. Vanda will supply the serotonin (5-HT2) receptor and dopamine receptor antagonist to Megapharm...
...option for co-commercialization rights or royalties (see BioCentury, June 14, 2004 & Oct. 19, 2009). Megapharm Ltd....

...Pharming granted MegaPharm Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary...
...Israeli commercialization rights to Ruconest conestat alfa to treat acute attacks of hereditary angioedema (HAE). MegaPharm...
...a supply price based on a percentage of net sales. Pharming is eligible for milestones. MegaPharm...